CA1033733A - Derives de amino-3 hydroxy-2 propoxy-1 phenylpyridazine - Google Patents

Derives de amino-3 hydroxy-2 propoxy-1 phenylpyridazine

Info

Publication number
CA1033733A
CA1033733A CA214,774A CA214774A CA1033733A CA 1033733 A CA1033733 A CA 1033733A CA 214774 A CA214774 A CA 214774A CA 1033733 A CA1033733 A CA 1033733A
Authority
CA
Canada
Prior art keywords
propoxy
hydroxy
amino
phenylpyridazine derivatives
phenylpyridazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA214,774A
Other languages
English (en)
Other versions
CA214774S (en
Inventor
William J. Coates
Anthony M. Roe
Robert A. Slater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Application granted granted Critical
Publication of CA1033733A publication Critical patent/CA1033733A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA214,774A 1973-12-19 1974-11-27 Derives de amino-3 hydroxy-2 propoxy-1 phenylpyridazine Expired CA1033733A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB58726/73A GB1488330A (en) 1973-12-19 1973-12-19 Dihydropyridazinones

Publications (1)

Publication Number Publication Date
CA1033733A true CA1033733A (fr) 1978-06-27

Family

ID=10482281

Family Applications (1)

Application Number Title Priority Date Filing Date
CA214,774A Expired CA1033733A (fr) 1973-12-19 1974-11-27 Derives de amino-3 hydroxy-2 propoxy-1 phenylpyridazine

Country Status (18)

Country Link
US (1) US3931177A (fr)
JP (1) JPS5093984A (fr)
BE (1) BE823103A (fr)
CA (1) CA1033733A (fr)
CH (1) CH608794A5 (fr)
DE (1) DE2459468A1 (fr)
DK (1) DK142870B (fr)
ES (1) ES433135A1 (fr)
FI (1) FI356974A7 (fr)
FR (1) FR2255070B1 (fr)
GB (1) GB1488330A (fr)
HU (1) HU170633B (fr)
IE (1) IE40428B1 (fr)
IL (1) IL46158A (fr)
NL (1) NL7416578A (fr)
SE (1) SE413405B (fr)
SU (1) SU578872A3 (fr)
ZA (1) ZA747462B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4111936A (en) * 1974-06-18 1978-09-05 Smith Kline & French Laboratories Limited Pyridazinethiones
US4082843A (en) * 1975-11-26 1978-04-04 Smith Kline & French Laboratories Limited 3-(3-(3-Substituted amino-2-hydroxypropoxy)phenyl)-6-hydrazino pyridazines and their use as vasodilators and β-adrenergic blocking agents
CH624395A5 (fr) * 1976-01-08 1981-07-31 Ciba Geigy Ag
US4258185A (en) * 1978-10-17 1981-03-24 Yoshitomi Pharmaceutical Industries, Ltd. Pyridazinone compounds
DE2845456A1 (de) * 1978-10-19 1980-08-14 Merck Patent Gmbh 6-arylpyridazin-3-one und verfahren zu ihrer herstellung
US4281125A (en) * 1980-05-15 1981-07-28 Diamond Shamrock Corporation Quinoline catalyzed synthesis of pyridazinone pharmaceutical intermediates
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
DE3263497D1 (en) * 1981-03-04 1985-06-20 Ciba Geigy Ag Pyridazinones, method for their preparation, pharmaceutical compositions containing these compounds and their use
GB8323553D0 (en) * 1983-09-02 1983-10-05 Smith Kline French Lab Pharmaceutical compositions
JPS6193169A (ja) * 1984-10-12 1986-05-12 Sankyo Co Ltd ピリダジノン誘導体及びその製法
GB8426804D0 (en) * 1984-10-23 1984-11-28 Ciba Geigy Ag Pyridazinones preparations
JPH0629254B2 (ja) * 1986-09-08 1994-04-20 帝国臓器製薬株式会社 ピリダジノン誘導体
DE3934436A1 (de) * 1989-06-01 1991-04-18 Thomae Gmbh Dr K 2-hydroxy-n-propylamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE19514568A1 (de) * 1995-04-20 1996-10-24 Merck Patent Gmbh Arylalkyl-pyridazinone
MXPA03011558A (es) 2001-06-12 2004-03-26 Wellstat Therapeutics Corp Compuestos para el tratamiento de desordenes metabolicos.
WO2004050657A2 (fr) * 2002-11-27 2004-06-17 Artesian Therapeutics, Inc. Composes presentant une activite mixte d'inhibition de la pde et d'antagoniste ou d'agoniste partiel ?eta-adrenergique pour traiter l'insuffisance cardiaque
JP2008521806A (ja) * 2004-11-30 2008-06-26 アーテシアン セラピューティクス， インコーポレイテッド 心不全を治療するための混合型のＰＤＥ−阻害活性およびβ−アドレナリン作用性アンタゴニスト活性または部分アゴニスト活性を有する化合物
US20080255134A1 (en) * 2004-11-30 2008-10-16 Artesian Therapeutics, Inc. Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase
WO2006127133A2 (fr) 2005-04-01 2006-11-30 Wellstat Therapeutics Corporation Composes pour le traitement de troubles metaboliques
UA95644C2 (ru) 2006-07-25 2011-08-25 Сефалон, Инк. Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
EP2142498A2 (fr) * 2007-04-02 2010-01-13 Institute for Oneworld Health Composés inhibiteurs de cftr et leurs utilisations
WO2009154754A2 (fr) * 2008-06-17 2009-12-23 Concert Pharmaceuticals, Inc. Synthèse de dérivés de morpholine deutérés
CA2903813C (fr) 2013-03-15 2023-08-29 Epizyme, Inc. Inhibiteurs de carm1 et leurs utilisations
EP2970266B1 (fr) 2013-03-15 2018-01-31 Epizyme, Inc. Dérivés de 1-phénoxy-3-(alkylamino)-propan-2-ol en tant qu'inhibiteurs de carm1 et leurs utilisations
US9346802B2 (en) 2013-03-15 2016-05-24 Epizyme, Inc. CARM1 inhibitors and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689652A (en) * 1970-10-09 1972-09-05 William Vincent Curran Method of lowering blood pressure in mammals
GB1383906A (en) * 1971-02-22 1974-02-12 Bdh Pharmaceuticals Ltd Pyridazinones

Also Published As

Publication number Publication date
IL46158A (en) 1978-08-31
IL46158A0 (en) 1975-02-10
GB1488330A (en) 1977-10-12
JPS5093984A (fr) 1975-07-26
IE40428L (en) 1975-06-19
ZA747462B (en) 1975-12-31
NL7416578A (nl) 1975-06-23
FI356974A7 (fr) 1975-06-20
IE40428B1 (en) 1979-05-23
FR2255070A1 (fr) 1975-07-18
SU578872A3 (ru) 1977-10-30
SE7415691L (fr) 1975-06-23
SE413405B (sv) 1980-05-27
AU7572474A (en) 1976-05-27
DK634074A (fr) 1975-08-25
DK142870B (da) 1981-02-16
HU170633B (fr) 1977-07-28
CH608794A5 (fr) 1979-01-31
US3931177A (en) 1976-01-06
DE2459468A1 (de) 1975-07-03
BE823103A (fr) 1975-06-09
FR2255070B1 (fr) 1979-09-21
DK142870C (fr) 1981-09-21
ES433135A1 (es) 1976-11-16

Similar Documents

Publication Publication Date Title
AU468242B2 (en) 2-cyclohexene-1-one derivatives
CA1020171A (fr) Derives de la 2-methylbenzamide
CA1033733A (fr) Derives de amino-3 hydroxy-2 propoxy-1 phenylpyridazine
CA1025856A (fr) Derives du quinoline-3-carboxamido-tetrazole
CA1029036A (fr) Derives d'octahydro-acetonaphtone
CA1018170A (en) Lactamimide derivatives
CA1019749A (fr) Derives de benzoxazolinone
AU472276B2 (en) Camparator circuitry
CA1018160A (en) Theophylline derivatives
CA1019752A (en) Heterocyclic anilids
AU474997B2 (en) Pyridazine derivatives
CA1024154A (fr) Derives de norsesquiterpene
AU458655B2 (en) Benzenesulfonylurea derivatives
CA1000699A (en) Quinazolinone derivatives
CA1002947A (en) Imidazo-benzodiazepine derivatives
CA1007249A (en) 4-alkoxy-4-phenylcyclohexylamine derivatives
AU487016B2 (en) Debenzocycoheptene derivatives
AU483899B2 (en) 7- methoxycephalosporin derivatives
AU495842B2 (en) Ryrimidine derivatives
AU480266B2 (en) 4-o-sulfonyl erythromycin-9-o-oxime derivatives
AU479245B2 (en) 8-azapurin-6-one derivatives
AU479187B2 (en) Triazolobenzoidiazepine derivatives
AU470521B2 (en) 5-benzyl-pyrimidine derivatives
AU482770B2 (en) 4-deoxy-4-oxoerythromycin b derivatives
AU7183874A (en) Debenzocycoheptene derivatives